ACN vs DXC: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: DXC is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ACN and DXC share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ACN and DXC exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Accenture is a global professional services company that helps businesses, governments, and other organizations across more than 120 countries build digital infrastructure, optimize operations, and accelerate growth. The company operates across five major service areas: Strategy and Consulting, Technology Services, Operations, Industry X (engineering and manufacturing digitization), and Song (marketing and customer experience). It earns revenue through a mix of consulting engagements, managed services contracts, and increasingly fixed-price, outcome-based arrangements, with managed services growing faster at roughly 10% year over year as of Q2 FY2026. The company serves clients in virtually every major industry vertical, from financial services and health to communications and government, and generates the majority of its revenue outside North America.

Full ACN guide

DXC Technology was formed in 2017 from the merger of Computer Sciences Corporation (CSC) and the enterprise services arm of Hewlett Packard Enterprise. It manages and modernizes technology for large companies and governments in roughly 70 countries, through two main segments: Global Infrastructure Services (GIS), which runs data centers, cloud, workplace and security operations, and Consulting and Engineering Services (CES), which covers application development, analytics, engineering and industry software, plus a large insurance software and business process unit. Much of its work is long-term outsourcing contracts on mission-critical systems, which makes revenue sticky but also exposes it to steady erosion as clients renegotiate, insource or move work to cheaper rivals and hyperscale clouds. The scale is still large: DXC employs on the order of 120,000 people and counts many Fortune 500 banks, insurers, airlines, automakers and government agencies as clients, often for systems that cannot be switched off for even an hour.

Full DXC guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ACN drivers: Enterprise AI implementation at scale; Shift to recurring, outcome-based revenue.
• DXC drivers: Stabilizing bookings; AI-led modernization services.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The most structural bear-case concern is AI cannibalization: if generative AI and agentic AI tools automate the coding, testing, documentation, and process management that make up a significant portion of Accenture's billable work, clients may require fewer hours per engagement, compressing revenue without a commensurate reduction in costs. For DXC, the core risk is that the revenue decline keeps compounding: organic revenue fell about 6.7% in the June 2026 quarter, worse than the full-year guidance midpoint, and a business that shrinks fast enough can see cash flow fall with it.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ACN if you believe its drivers more; DXC if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ACN and DXC guides.

ACN. At ~$227.69 on October 16, 2026, Accenture trades at about 16.8x trailing earnings and ~14.3x forward estimates, up from roughly 10 to 13x in June after a ~62% three-month rally, though still below its 5-year average near 25x. Consensus calls for fiscal 2027 EPS of ~$14.66 on ~$77.4 billion of revenue, and trailing free cash flow of ~$11.2 billion covers the dividend (about a 51% payout ratio) and buybacks. The next report, for the quarter ending November 30, is scheduled for December 17, 2026.

DXC. At about $13.79 a share (the October 15, 2026 close, within a 52-week range of roughly $7.90 to $15.68), DXC trades at about 4.8 to 5.7 times its guided non-GAAP earnings and a double-digit free cash flow yield, among the lowest multiples in large-cap IT services. That discount reflects years of shrinking revenue and repeated misses rather than an overlooked bargain by default, and analyst coverage in mid-2026 was uniformly at Hold with targets near $11. The next earnings report, for the September 2026 quarter, was expected around October 29, 2026, with options implying a move of roughly 15%. For comparison, larger rivals such as Accenture have historically traded at well over 20 times earnings, and even fellow turnaround Kyndryl has carried a materially higher multiple, which shows how much of DXC's discount is tied to its specific growth record rather than the sector as a whole.

Headline figures (approximate, October 2026): ACN shows revenue (fy2026, ended aug 31 2026) ~$74.2 billion (+~6.5% YoY), q4 fy2026 revenue ~$18.7 billion (+~6.2% YoY), q4 fy2026 eps ~$3.29 (vs ~$3.18 consensus), net income (fy2026) ~$8.4 billion (~11.3% net margin); DXC shows revenue (ttm) ~$12.5 billion, fy2027 revenue guidance ~$12.1 to $12.35 billion (organic -3% to -5%), non-gaap eps guidance (fy2027) ~$2.40 to $2.90, free cash flow (fy2026) ~$713 million.

ACN and DXC are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ACN and DXC exposure against your real portfolio. It is not an investment adviser.